Swiss National Bank Has $95.17 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Swiss National Bank increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,336,987 shares of the company’s stock after purchasing an additional 86,000 shares during the quarter. Swiss National Bank’s holdings in GE HealthCare Technologies were worth $95,167,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Mediolanum International Funds Ltd bought a new stake in GE HealthCare Technologies in the first quarter valued at $1,623,000. Jennison Associates LLC grew its position in GE HealthCare Technologies by 19.1% during the 1st quarter. Jennison Associates LLC now owns 695,019 shares of the company’s stock worth $49,471,000 after acquiring an additional 111,434 shares during the last quarter. Atlas Wealth LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter valued at $4,594,000. Assetmark Inc. increased its holdings in GE HealthCare Technologies by 2.5% during the 1st quarter. Assetmark Inc. now owns 12,939 shares of the company’s stock valued at $921,000 after purchasing an additional 319 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in GE HealthCare Technologies by 17.8% in the 1st quarter. Bessemer Group Inc. now owns 9,727 shares of the company’s stock valued at $692,000 after purchasing an additional 1,470 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. BMO Capital Markets assumed coverage on GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective on the stock. Hovde Group started coverage on GE HealthCare Technologies in a research note on Friday. They issued a “market perform” rating and a $14.00 target price for the company. HSBC dropped their target price on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Finally, Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Trading Down 0.4%

Shares of NASDAQ:GEHC opened at $62.83 on Tuesday. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company’s fifty day simple moving average is $63.67 and its 200 day simple moving average is $71.74. The firm has a market cap of $28.58 billion, a price-to-earnings ratio of 15.03, a PEG ratio of 1.72 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the previous year, the company posted $1.01 EPS. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Transactions at GE HealthCare Technologies

In related news, Director Watkin Phoebe L. Yang purchased 1,000 shares of the stock in a transaction on Friday, May 8th. The shares were purchased at an average cost of $63.01 per share, with a total value of $63,010.00. Following the acquisition, the director directly owned 13,702 shares in the company, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Rodney F. Hochman bought 1,618 shares of the stock in a transaction dated Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have purchased 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.